

| Particulars (in ₹ Cr.) | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|
| Total Revenue | 103.44 | 404.02 | 404.02 | 287.50 | 162.37 |
| Total Expenses | 137.71 | 389.15 | 389.15 | 269.83 | 152.53 |
| Profit Before Tax | -34.27 | 14.87 | 14.87 | 17.67 | 9.84 |
| Profit After Tax | -34.82 | 13.67 | 13.67 | 15.67 | 9.84 |
| Operating Profit After Depreciation | -10.29 | 33.28 | 33.28 | 38.25 | 23.32 |
| Particulars (in ₹ Cr.) | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|
| Fixed Assets | 103.52 | 107.77 | 107.77 | 100.17 | 110.09 |
| Total Non Current Assets | 105.77 | 110.69 | 110.69 | 113.66 | 110.09 |
| Total Current Assets | 289.81 | 300.99 | 300.99 | 231.95 | 139.90 |
| Total Assets | 395.58 | 411.68 | 411.68 | 345.61 | 249.99 |
| Total Shareholder's Fund | 53.08 | 87.89 | 87.89 | 73.90 | 61.40 |
| Particulars (in ₹ Cr.) | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| Net Cash From Operating Activities | 6.72 | 6.72 | 36.72 | 63.89 |
| Net Cash Used In Investing Activities | -4.71 | -4.71 | -6.99 | -14.43 |
| Net Cash Used In Financing Activities | -12.85 | -12.85 | -38.39 | -26.82 |
| Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Total Revenue | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 |
| Total Expenses | 5.57 | 15.24 | 19.27 | 21.04 | 22.31 |
| Profit Before Tax | -5.55 | -15.23 | -19.23 | -21.01 | -24.46 |
| Profit After Tax | -5.55 | -15.23 | -19.23 | -21.01 | -24.46 |
| Operating Profit After Depreciation | -5.55 | -15.09 | -8.39 | -6.53 | -7.83 |
| Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Fixed Assets | 37.59 | 41.66 | 56.91 | 62.54 | 68.42 |
| Total Non Current Assets | 37.59 | 41.66 | 71.36 | 76.99 | 82.87 |
| Total Current Assets | 37.74 | 37.53 | 159.23 | 159.34 | 156.58 |
| Total Assets | 75.33 | 79.19 | 230.59 | 236.33 | 239.45 |
| Total Shareholder's Fund | -127.98 | -122.43 | -107.20 | -87.97 | -66.96 |
| Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 0.87 | 93.76 | 2.51 | 14.48 | 20.95 |
| Net Cash Used In Investing Activities | - | 25.09 | - | - | - |
| Net Cash Used In Financing Activities | -0.87 | -120.28 | -1.08 | -14.47 | -20.95 |
No data available
| Particulars (in ₹ Cr.) | 2024-06 | 2024-03 | 2023-12 | 2023-09 | 2023-06 |
|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - |
| Total Expenses | 0.34 | 0.25 | 0.20 | 0.20 | 0.23 |
| Profit Before Tax | -1.33 | -1.26 | -1.23 | -1.22 | -1.22 |
| Profit After Tax | -1.33 | -1.26 | -1.23 | -1.22 | -1.23 |
| Operating Profit after Depreciation | -0.32 | -0.25 | -0.20 | -0.20 | -0.21 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
No data available

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.